FLOWERS LEE (SVP of Business Development) purchased 9.9% of their position (10K shares) of HCW BIOLOGICS INC. on the open market
Open‑market purchase worth $21.6K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/9/2023ACC: 0001209191-23-036087
Officer· SVP of Business Development
Since Jul 2021
+10K
Net shares
Net buyer
$22.3K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
15.36K acquired · 5.36K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.36K
Price / share
$0.14
Trade value
$749.84
% of position
5.6%
6/8/2023
95.95K→101.31K
Common Stock
Direct
Shares
+10K
Price / share
$2.16
Trade value
$21.57K
% of position
9.9%
6/8/2023
101.31K→111.31K
Total
Net shares
+15.36K
Net value
$22.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/8/2023 | M · Option Exercise | +5.36K | $0.14 | $749.84 | 5.6% | 95.95K | 101.31K |
| Common Stock Direct | 6/8/2023 | P · Purchase | +10K | $2.16 | $21.57K | 9.9% | 101.31K | 111.31K |
| Total | +15.36K | $22.32K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5.36K shares
Shares
−5.36K
Strike price
0.14
Held after
7.50K
Exercisable
—
6/8/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5.36K shares | 6/8/2023 | M · Option Exercise | −5.36K | 0.14 | — | 7.50K |